4
Changes in Ownership
Nurix Therapeutics, Inc. Filed Acc 0001549595-25-000002
Chief Legal Officer sold 5,760 shares at $19.50 ($112,295)
- Chief Legal Officer acquired 5,760 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Ring Christine · Chief Legal Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-01-02 | Exercise or conversion : show line 1 in the form 10b5-1 | +5,760 | $1.86 | $10,714 | 33,844 | D |
| 2025-01-02 | Sale : show line 2 in the form 10b5-1 | −5,760 | $19.50 | $112,295 | 28,084 | D |
| Open-market sales · 5,760 sh · avg $19.50 · $112,295 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-01-02 | Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (right to buy) | −5,760 | 53,986 | D |
Loading xslF345X05/wk-form4_1735856926.xml…